Vaccines: the pentavalent rotavirus vaccine: discovery to licensure and beyond

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Penny Heaton, Max Ciarlet

Abstract

Twenty-five years passed between the discovery of the parent strain (WC3) of the pentavalent human-bovine reassortant rotavirus vaccine (PRV) in 1981 and the licensure of PRV in 2006. This orally administered liquid vaccine, which is given as a 3-dose series, is indicated for the prevention of rotavirus gastroenteritis, caused by the G serotypes contained in the vaccine, in infants and children. PRV is recommended by the Advisory Committee on Immunization Practices and the American Academy of Pediatrics for administration to all infants in the United States. These recommendations are supported by the results of the phase III studies, which demonstrated that PRV is well tolerated and efficacious. PRV reduced rotavirus-related hospitalizations by 96% and was not associated with an increased incidence of serious adverse events, including intussusception. This report focuses on the safety and efficacy data from the late-phase studies of PRV and discusses plans for providing this vaccine to the developing world.

References

Apr 1, 1995·The Pediatric Infectious Disease Journal·J J TreanorP Offit
Mar 1, 1993·The Journal of Infectious Diseases·D O MatsonM K Estes
Sep 1, 1996·The Journal of Infectious Diseases·H F ClarkS A Plotkin
Oct 3, 1996·The New England Journal of Medicine·F R VelázquezG M Ruiz-Palacios
Nov 9, 2000·The Journal of Infectious Diseases·F R VelázquezG M Ruiz-Palacios
Feb 24, 2001·The New England Journal of Medicine·T V MurphyUNKNOWN Rotavirus Intussusception Investigation Team
Nov 29, 2002·Pediatrics·Georges PeterUNKNOWN National Vaccine Program Office
May 10, 2003·Emerging Infectious Diseases·Umesh D ParasharRoger I Glass
Aug 10, 2005·The Journal of Infectious Diseases·Roger I GlassA Duncan Steele
Jan 6, 2006·The New England Journal of Medicine·Guillermo M Ruiz-PalaciosUNKNOWN Human Rotavirus Vaccine Study Group
Jan 6, 2006·The New England Journal of Medicine·Timo VesikariUNKNOWN Rotavirus Efficacy and Safety Trial (REST) Study Team
Jan 4, 2007·Pediatrics·Allison KempeStephen Berman

❮ Previous
Next ❯

Citations

Jun 10, 2011·Virus Genes·Dai YamamotoNobumichi Kobayashi
May 2, 2009·Archives of Pharmacal Research·Kyungdong BaeByungki Hur
Dec 17, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Richard L Ward, David I Bernstein
May 6, 2010·The Pediatric Infectious Disease Journal·Timo VesikariMax Ciarlet
May 15, 2012·The Pediatric Infectious Disease Journal·Maria Hemming, Timo Vesikari
Dec 10, 2009·Future Microbiology·Jelle MatthijnssensMarc Van Ranst
May 23, 2012·The Journal of Infectious Diseases·Celeste M DonatoCarl D Kirkwood
Oct 1, 2014·Critical Reviews in Microbiology·Zenas Kuate Defo, Byong Lee
Sep 29, 2009·Veterinary Microbiology·V MartellaMax Ciarlet
Oct 1, 2013·The Journal of General Virology·Giovanni M GiammancoSimona De Grazia
Sep 18, 2008·The Journal of General Virology·Jelle MatthijnssensMarc Van Ranst
Jul 6, 2010·Journal of Virological Methods·Pamela K MathisTodd S Ranheim
Jul 31, 2016·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·S AnandS K Tomar
Sep 30, 2016·Frontiers in Pharmacology·Yuanyuan SunGuang Du
Sep 7, 2011·Memórias do Instituto Oswaldo Cruz·Antoine Chaouki El KhouryMaria Lucia Rácz
Jul 29, 2010·Veterinary Research·Patrick J CollinsHelen O'Shea
Mar 20, 2020·Viruses·Marcelle Silva-SalesRosina Gironès
Jan 8, 2021·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Shilu MathewHadi M Yassine
May 1, 2021·Pharmaceuticals·Tapan BehlDomenico Montesano

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.